LENZ
LENZ
NASDAQ · Pharmaceuticals

Lenz Therapeutics Inc

$5.75
-0.07 (-1.20%)
As of Jun 23, 10:04 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +143.1% upside
Low Target $9.74
Average Target $13.98
High Target $16.17
Current Price $5.75
Current
$5.75
Target
$13.98
$9.74 $13.98 avg $16.17
Scenario Analysis
Bear Case
$9.74
69.4%
Low target
Base Case
$13.98
+143.1%
Avg target
Bull Case
$16.17
+181.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$50.40
-88.6% from high
52-Week Low
$5.84
+-1.5% from low
Target vs 52W High
$13.98
-72.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%